Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
773.00    -11.50 (-1.47%)
Bid:
777.50
Ask:
778.00
Spread: 0.50 (0.064%)
Market Cap: £2.60b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

2 Jun 2025 14:55

RNS Number : 0744L
Drax Group PLC
02 June 2025
 

2 June 2025

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 28 February 2025, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 to purchase ordinary shares of 11 16/29 pence each in the Company (the "Programme"), it was commencing the third tranche of the Programme up to a maximum consideration of £75 million (the "Third Tranche"). As at 30 May 2025, the Company had repurchased a total of 36,102,728 shares for a consideration of c.£225 million in aggregate across the First, Second and Third Tranches.

 

The Company is today confirming that the fourth tranche of the Programme to purchase ordinary shares in the Company up to a maximum consideration of £75 million (the "Fourth Tranche") will now commence, following the conclusion of the Third Tranche on 30 May 2025.

 

The purpose of the Fourth Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Fourth Tranche will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the Fourth Tranche of the Programme is 33,469,342 being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 1 May 2025 less the shares acquired under the Third Tranche since 1 May 2025.

 

The programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc"), pursuant to which JPMS plc shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company. JPMS plc will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company.

 

This arrangement is in accordance with Chapter 9 of the United Kingdom Financial Conduct Authority Listing Rules and the Company's general authority to repurchase shares.

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcements on 7 August 2024, 22 October 2024 and 28 February 2025 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Chris Mostyn

+44 (0) 7743 963 483

 

J.P. Morgan

Robert Constant / Alia Malik

+44 (0) 20 3493 8000

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGGVFZZGKZM
Date   Source Headline
1st Dec 20217:02 amRNSCapital Markets Day - Update
1st Dec 20217:00 amRNSTrading Update
22nd Nov 20212:25 pmRNSNotice of Capital Markets Day
5th Nov 20218:30 amRNSAdditional Listing
1st Nov 20213:07 pmRNSTotal Voting Rights
21st Oct 20211:30 pmRNSAppointment of Non-Executive Directors
6th Oct 20218:00 amRNSBlock listing Interim Review - PSP
6th Oct 20218:00 amRNSBlock listing Interim Review - SAYE
6th Oct 20218:00 amRNSBlock listing Interim Review - DSP
4th Oct 202112:11 pmRNSTotal Voting Rights
27th Sep 20218:00 amRNSAdditional Listing
23rd Sep 202111:00 amRNSINTENTION TO CONDUCT AUDIT TENDER
19th Aug 20213:34 pmRNSDirector/PDMR Shareholding
9th Aug 202111:13 amRNSLTIP 2021 – EPS Performance Condition
2nd Aug 20211:12 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSHalf-year Report
22nd Jul 20217:40 amRNSNotice of Results
13th Jul 20217:00 amRNSRefinancing of Pinnacle Debt
8th Jul 20212:54 pmRNSHolding(s) in Company
1st Jul 202112:51 pmRNSTotal Voting Rights
1st Jul 202112:49 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSAcquisition of Joint Venture Interest
29th Jun 202110:38 amRNSHolding(s) in Company
15th Jun 20218:00 amRNSAdditional Listing
4th Jun 202111:19 amRNSHolding(s) in Company
4th Jun 202111:15 amRNSTotal Voting Rights
20th May 20218:00 amRNSHolding(s) in Company
5th May 202112:09 pmRNSHolding(s) in Company
5th May 20218:00 amRNSTotal Voting Rights
4th May 20219:30 amRNSNotice of Change to Director Details
29th Apr 202110:01 amRNSHolding(s) in Company
28th Apr 20218:00 amRNSAdditional Listing
23rd Apr 20213:12 pmRNSHolding(s) in Company
21st Apr 20212:00 pmRNSResult of AGM
21st Apr 20217:00 amRNSTrading Update
15th Apr 20219:29 amRNSHolding(s) in Company
13th Apr 20218:00 amRNSCompletion of acquisition
8th Apr 202110:08 amRNSHolding(s) in Company
7th Apr 20217:11 amRNSSatisfied conditions for proposed acquisition
1st Apr 20214:00 pmRNSBlock listing Interim Review - DSP
1st Apr 20213:58 pmRNSBlock listing Interim Review - PSP
1st Apr 20213:55 pmRNSBlock listing Interim Review - Sharesave
1st Apr 20212:10 pmRNSTotal Voting Rights
1st Apr 20212:01 pmRNSDirector/PDMR Shareholding
31st Mar 20215:03 pmRNSResult of Meeting
18th Mar 20219:00 amRNSMailing of Annual Report and Notice of AGM
12th Mar 202112:51 pmRNSProposed acquisition by Drax Group
11th Mar 20217:00 amRNSCapacity Market Agreements
9th Mar 20219:30 amRNSDirector/PDMR Shareholding
3rd Mar 20214:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.